← All trials
NCT05440773
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 30, 2023
- Primary completion
- Jun 30, 2023
- Completion date
- Feb 29, 2024
- First posted
- Jul 1, 2022
- Last posted
- Jul 1, 2022
- Enrollment
- 112
- Arms / groups
- 8 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Université catholique de LouvainLead sponsor
- Université catholique de LouvainOverall official - principal investigator
- Université catholique de LouvainStudy director
- University of LiegeStudy chair
- Free University of BrusselsStudy chair
- Université catholique de LouvainOfficial
- Université catholique de LouvainOfficial
- Free University of BrusselsOfficial
- University of LiegeOfficial
- University of BueaOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.